MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fendo.2025.1653881

Медицинская библиотека · Frontiers in endocrinology · 2025

The ProCVT smart-sheet as a new screening tool for cardiovascular autonomic neuropathy: a feasibility study.

Bitsch Poulsen Maria, Julu Peter, Røikjer Johan, Drewes Asbjørn Mohr, Brock Christina

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Cardiovascular autonomic neuropathy (CAN) is a severe complication of diabetes that impairs the regulation of the cardiovascular system. This can cause hemodynamic instability, arrhythmias, and silent ischemia. Despite its clinical significance, routine testing is not widely implemented. Therefore, this study investigated the performance of a novel screening tool, the ProCVT smart-sheet, based on electrocardiography (ECG)-derived cardiac vagal tone (CVT), compared to standardized methods in type 2 diabetes (T2D).

METHODS

Forty individuals with T2D (aged 45-75) with varying degrees of CAN and 20 age-matched controls were included in this cross-sectional study. Autonomic profiling included cardiovascular autonomic reflex tests, short-term CVT, 72-hour blood pressure monitoring, and three nights of home monitoring with the ProCVT smart-sheet. Receiver operating characteristics assessed the performance of long-term and short-term CVT to detect any, early-stage, and manifest CAN.

RESULTS

A total of 164 recordings were obtained, with an average of 93% of each recording classified as very high signal quality before artifact removal. Short- and long-term mean CVT were the best-performing parameters, identifying any and manifest CAN with AUCs of 0.64-0.79. Suggested cut-offs were 2.7 linear vagal scale (LVS) units for short-term and 5.0 LVS for long-term recordings.

CONCLUSION

The ProCVT smart-sheet offers a feasible, non-invasive alternative to traditional ECGs that rely on surface electrodes. CVT shows promise as a biomarker for identifying manifest CAN in T2D. However, long-term recordings of CVT were not superior to short-term recordings. Further research is warranted to assess its value in the detection of early-stage CAN.

Для цитирования: Bitsch Poulsen Maria, Julu Peter, Røikjer Johan, Drewes Asbjørn Mohr, Brock Christina. The ProCVT smart-sheet as a new screening tool for cardiovascular autonomic neuropathy: a feasibility study.. Frontiers in endocrinology. 2025. DOI: 10.3389/fendo.2025.1653881.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.